Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Smaller DTC Budgets, But More Info-Packed Drug Ads Expected In 2009

Executive Summary

Drug companies will continue to scale back funds for televised ads in 2009, largely in order to save money, but also because they are increasingly sensitive to public perception at a time when consumers are struggling financially

You may also be interested in...

Prevacid, Topamax Among Blockbusters Set To Lose Exclusivity In ’09

At least four blockbuster drugs could face generic rivals in the U.S. for the first time in 2009

FDA Advertising Oversight Will Consider Impact Of “Puppies” And The Internet

FDA is pushing forward several research initiatives to help better define how print and broadcast direct-to-consumer ads should be structured, but the agency is adopting a less formal approach to oversight of Internet advertising

Big Pharma Still Hopeful For Next Mega Drugs To Supplement Sales

Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts